Element Squared’s Zevra Therapeutics ZVRA Stock Holding History

Element Squared’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$664K	Buy	+46,336	New	+$515K	0.33%	46

Other funds holding ZVRA

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

IFG Advisors St. Louis, Missouri $725M AUM 27.52% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return

Element Squared's ZVRA Position: Q2 2026 in Review

Element Squared opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 46,336 shares worth $664K. The stake represents 0.33% of the portfolio and ranks #46 among its holdings.

31 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Element Squared held 46,336 shares of Zevra Therapeutics worth $664K as of Q2 2026.
Zevra Therapeutics was a new Element Squared position in Q2 2026.
Zevra Therapeutics made up 0.33% of Element Squared's portfolio in Q2 2026, its #46 holding.
31 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Element Squared's 13F filing for Q2 2026, filed 28 Jul 2026.